Bristle vs. ProBiora: Which Oral Probiotic Actually Fights Bad Breath?
Both claim to improve oral health through probiotics, but they use completely different bacterial strains. Here's how they compare on the evidence that matters for bad breath.
Our Verdict
Bristle wins on bad-breath-specific strain evidence. ProBiora uses different strains with less direct evidence for VSC reduction.
Oral probiotics are a growing category, but the science is not equally developed for all strains. When the specific goal is reducing bad breath, the strain selection is everything. Bristle and ProBiora take completely different approaches — and the distinction matters if you’re buying a product specifically for halitosis.
The Strain Difference
Bristle Oral Health Probiotic uses six strains: S. salivarius K12, S. salivarius M18, L. reuteri, L. salivarius, L. plantarum, and B. lactis. K12 and M18 are the two most studied oral probiotic strains for bad breath. K12 produces bacteriocin-like inhibitory substances (BLIS) that suppress VSC-producing anaerobes. M18 has shown additional antibacterial and anti-biofilm effects in independent studies.
ProBiora Health ProBiora3 uses three strains: S. oralis KJ3, S. uberis KJ2, and S. rattus JH145. These are proprietary strains selected and studied internally by ProBiora. They are not the same organisms as K12 or M18. ProBiora’s own research shows some benefits for plaque and gum health, but independent clinical trials specifically targeting VSC reduction with ProBiora’s strains are limited.
Head-to-Head Comparison
| Feature | Bristle Oral Health Probiotic | ProBiora Health ProBiora3 |
|---|---|---|
| Number of strains | 6 | 3 |
| S. salivarius K12 included | ✓ | ✗ |
| S. salivarius M18 included | ✓ | ✗ |
| VSC-reduction clinical evidence | Yes — independent studies on K12 and M18 | Limited — primarily proprietary internal research |
| Independent clinical trials | Yes (K12/M18) | Limited |
| Form factor | Lozenge (dissolves in mouth) | Lozenge (dissolves in mouth) |
| Price (30-day supply) | $29.99 | ~$30–35 |
| Clean ingredients | Xylitol-based, dairy/gluten/GMO free | Xylitol-based |
The Evidence Gap
The key differentiator is independent clinical evidence. S. salivarius K12 has been studied in multiple independent trials — not just by the company that produces it — with peer-reviewed results published in journals like the Journal of Applied Microbiology and Acta Odontologica Scandinavica. Those studies show measurable reductions in VSC levels and breath scores.
ProBiora’s strains (S. oralis, S. uberis, S. rattus) have a more limited independent evidence base for bad breath specifically. The company’s research is real, but the body of independent replication is thinner, and the proposed mechanism is less directly tied to VSC production suppression.
This doesn’t mean ProBiora has no effect — but if you’re choosing a probiotic specifically to address bad breath, the K12/M18 combination has a stronger foundation in external, peer-reviewed research.
When ProBiora Might Be the Right Choice
If your primary interest is general oral health — plaque reduction, whitening effect, or gum health — and bad breath is a secondary concern, ProBiora is a legitimate option. Some users report noticeable whitening and fresher breath. The proprietary strains may have real benefits that future research will better characterize.
But for targeted bad-breath reduction with the strongest current evidence behind it, K12 and M18 are the strains to prioritize.
What We Use and Recommend
The Oral Probiotic With the Best Strain Evidence for Bad Breath
The Bristle Oral Health Probiotic is the only 6-strain formula that combines S. salivarius K12 and M18 — the two strains with the strongest clinical evidence for reducing the gases that cause bad breath.
References
- [1] Burton JP, Chilcott CN, Moore CJ, et al.. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol.2006. DOI: 10.1111/j.1365-2672.2006.02969.x
- [2] Keller MK, Hasslöf P, Stecksén-Blicks C, Twetman S. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci. Acta Odontol Scand.2011.
- [3] Scariya L, Nagarathna DV, Varghese M. Probiotics in periodontal therapy. Int J Pharm Bio Sci.2015.